Analyst Rating
based on 26 analysts
26.92%
Buy
26.92%
Hold
46.15%
Sell
Based on 26 analysts offering long term price targets for Divis Laboratories Ltd. An average target of ₹4457.08
Source: S&P Global Market Intelligence
Divis Laboratories Ltd Share analysis
Divis Laboratories Ltd price forecast by 26 analysts
Downside of
High
₹5740
Target
₹4457.08
Low
₹3000
Divis Laboratories Ltd target price ₹4457.08, a slight downside of -18.51% compared to current price of ₹5429.2. According to 26 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Divis Laboratories Ltd revenue growth forecast
Expected growth rate Q1, FY2026:35.28%
Forecast
Actual
Including amortisation and stock based compensations
Divis Laboratories Ltd EPS growth forecast
EPS estimate Q1, FY2026:61.73%
Forecast
Actual
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹5,419₹5,51352 Week's Low
52 Week's High
₹3,295.3₹5,560
| Returns % | |
| 1 Month Return | + 17.11 % |
| 3 Month Return | + 22.09 % |
| 1 Year Return | + 44.7 % |
| Market Stats | |
| Previous Close | ₹5,469.15 |
| Open | ₹5,469.15 |
| Volume | 3.42L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,45,188.75Cr |
Key Statistics
| P/E Ratio | 86.73 |
| PEG Ratio | 11.72 |
| Market Cap | ₹1,45,188.75 Cr |
| P/B Ratio | 6.75 |
| EPS | 60.38 |
| Dividend Yield | 0.87 |
| Sector | Pharmaceuticals |
| ROE | 12.04 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹1,45,188.75 Cr | 49.12% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
| BUY | ₹1,13,699.02 Cr | 58.95% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
| HOLD | ₹43,659.82 Cr | 12% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
| HOLD | ₹30,339.03 Cr | 0.24% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
| BUY | ₹1,33,377.76 Cr | 53.07% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
Company Information
Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.
Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.
Share Price: ₹5429.20 per share as on 19 Sep, 2024 04:01 PM
Market Capitalisation: ₹1,45,188.75Cr as of today
Revenue: ₹2,118.00Cr as on June 2024 (Q2 24)
Net Profit: ₹430.00Cr as on June 2024 (Q2 24)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
| Organisation | Divis Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Divis Laboratories Ltd
Divis Labs Receives Stable Rating from CARE Ratings - 16 Sep, 2024
CARE Ratings reaffirmed Divis Laboratories' long-term rating at CARE AA+ with a stable outlook, citing strong management, R&D capabilities, and favorable industry outlook.
Divis Laboratories Shows Strong Bullish Momentum - 09 Sep, 2024
Divis Laboratories Ltd has been outperforming frontline indices and the Nifty Pharma index, indicating positive momentum. Trading at a 52-week high, all indicators suggest strong bullish trends, making it a favorable buy.
Divis Labs Shows Bullish Signals for Investors - 29 Aug, 2024
Divis Laboratories is forming higher highs and lows, indicating an uptrend. A rounding bottom pattern on the weekly chart and a bullish RSI crossover suggest strength. Investors are advised to buy at current prices up to Rs 4,980, with a target of Rs 5,250.
Divis Labs Faces Resistance Near Historical Highs - 27 Aug, 2024
Divis Laboratories Ltd is trading around Rs 4,900, nearing its historical high range of Rs 5,200-5,300. A bearish bat pattern suggests potential reversal, and investors are advised to book profits if the stock approaches the Rs 5,000-5,200 range.
Divis Laboratories to Exit Nifty50 Index - 26 Aug, 2024
Divis Laboratories is set to be removed from the Nifty 50 index effective September 30, 2024. Despite this, the stock saw an intraday high of Rs 4,922.
Divis Laboratories Gains from US Court Ruling - 21 Aug, 2024
Divis Laboratories saw a significant share price increase following a favorable US court ruling that stayed FDA approval for a competing generic drug. The company reported strong Q1 FY25 earnings, with a 21% rise in net profit and a 19% increase in revenue, reflecting robust performance in the pharmaceutical sector.
Divis Laboratories Poised for Growth with New Capex - 19 Aug, 2024
Divis Laboratories is experiencing decent growth, with the commissioning of its Vizag facility expected to enhance value and margins. The upcoming capex announcement will be crucial for assessing future asset returns and margins.
Insights on Divis Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, DIVISLAB stock has moved up by 17.1%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 14.68% to 16.16% in Jun 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 142.7% return, outperforming this stock by 135.7%
- NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 78.3% return, outperforming this stock by 33.6%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 51.92% to 51.90% in Jun 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 538.0 Cr → 430.0 Cr (in ₹), with an average decrease of 20.1% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.38K Cr → 2.19K Cr (in ₹), with an average decrease of 7.8% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 14.28% to 13.10% in Jun 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 11.19% to 10.18% in Jun 2024 quarter
News
Divis Laboratories Share Price Today Up 3%
Real-time updates on Divis Laboratories share price. Check out the detailed analysis of the company in this live blog.29 Jul, 2024 05:30 PMTrent and BEL could join Nifty in September rejig; LTIM, Divi's Likely to exit
Tata Group's Trent and Bharat Electronics were poised to join the Nifty 50 index during the September reshuffle, as predicted by IDBI Capital. Trent's shares increased 84% and Bharat Electronics rose 68% this year. LTI Mindtree and Divi's Laboratories were likely to be excluded. The index review is based on semi-annual market data, effective from September 30.31 Jul, 2024 07:39 AMPrice Updates: Divis Laboratories Hits New 52-Week High at Rs 4953.20, Registers 0.61% Increase
Discover the Divi's Laboratories Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track of Divi's Laboratories's latest details, including: Last traded price 4944.25, Market capitalization: 130695.49, Volume: 19961, Price-to-earnings ratio 81.68, Earnings per share 60.27. Our liveblog offers a holistic view of Divi's Laboratories by examining both fundamental and technical indicators. Stay ahead of market trends with breakingnews that can impact Divi's Laboratories's performance. Our market analysis and expert opinions provide valuable insights to guide your investment decisions. Join us on the Divi's Laboratories Stock Liveblog and stay informed in this dynamic market landscape. The data points are updated as on 01-08-2024 09:20 IST01 Aug, 2024 08:33 AMCompany Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 51.9% | ||
| Foreign Institutions | 16.16% | 10.05 | |
| Mutual Funds | 13.1% | ||
| Retail Investors | 10.18% | ||
| Others | 8.67% | 9.33 |
Key Indicators
Divis Laboratories Ltd Valuation
Divis Laboratories Ltd in the last 5 years
Lowest (28.97x)
November 21, 2022
Industry (58.50x)
September 18, 2024
Today (86.73x)
September 18, 2024
Highest (87.20x)
September 13, 2024
Earnings and Dividends
Divis Laboratories Ltd Earnings Results
Divis Laboratories Ltd’s net profit jumped 20.79% since last year same period to ₹430Cr in the Q1 2024-2025. On a quarterly growth basis, Divis Laboratories Ltd has generated -20.07% fall in its net profits since last 3-months.
Read More about Earnings ResultsDivis Laboratories Ltd Dividends May,2024
In the quarter ending March 2024, Divis Laboratories Ltd has declared dividend of ₹30 - translating a dividend yield of 0.55%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Divis Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Divis Laboratories Ltd shares.
Divis Laboratories Ltd (DIVISLAB) share price today is ₹5429.2
Divis Laboratories Ltd is listed on NSE
Divis Laboratories Ltd is listed on BSE
- Today’s highest price of Divis Laboratories Ltd is ₹5513.
- Today’s lowest price of Divis Laboratories Ltd is ₹5419.
PE Ratio of Divis Laboratories Ltd is 86.73
PE ratio = Divis Laboratories Ltd Market price per share / Divis Laboratories Ltd Earnings per share
Today’s traded volume of Divis Laboratories Ltd(DIVISLAB) is 3.42L.
Today’s market capitalisation of Divis Laboratories Ltd(DIVISLAB) is ₹145188.75Cr.
| Divis Laboratories Ltd(DIVISLAB | Price |
|---|---|
52 Week High | ₹5560 |
52 Week Low | ₹3295.3 |
Divis Laboratories Ltd(DIVISLAB) share price is ₹5429.2. It is down -2.35% from its 52 Week High price of ₹5560
Divis Laboratories Ltd(DIVISLAB) share price is ₹5429.2. It is up 64.76% from its 52 Week Low price of ₹3295.3
| Divis Laboratories Ltd(DIVISLAB | Returns |
|---|---|
1 Day Returns | -39.95% |
1 Month Returns | 17.11% |
3 Month Returns | 22.09% |
1 Year Returns | 44.7% |